Engaging HCP Communities
With grateful thanks to our sponsor
Through the MedShr app, this programme leveraged case-based education to enhance healthcare in low- and middle-income countries (LMICs) affected by sickle cell disease (SCD).
Reaching more than 70,000 healthcare professionals and community health workers, it significantly boosted knowledge, confidence, and clinical capabilities regarding SCD newborn screening and management. The targeted peer-to-peer learning approach, coupled with low-bandwidth accessibility, equipped healthcare providers to learn and apply best practices, ultimately fostering better patient outcomes and more effective disease management in challenging resource settings.
Judges Comments
This highly pragmatic campaign utilises real insights about the lack of access to newborn screening in some parts of the world to effectively meet the objectives of the brief and the wider purpose of the Novartis programme, to bridge the disparities in disease management and outcomes between low- and middle-income countries and the rest of the world, by enabling and engaging the HCP community in those areas.
Successfully adapted for the particular issue and markets, and with 92% of users finding the App useful for clinical decision-making, the judges noted that this represents an extremely high clinical impact towards the programme’s aims and therefore, it was a rightful Gold in this category. campaign.
Shirani Meyer, Assoc Director CV portfolio UK/I, Britsol Myers Squibb
In 2022, an estimated 80% of second-line diffuse large B-cell lymphoma patients were eligible for CAR T-cell therapy, but only 16% received it; many patients who could be benefiting from this curative treatment were not receiving it.
The Cell Therapy Hub is the centre of an international ecosystem for HCPs outside of the US. We set out to transcend the current standard of medical education and deliver individual learning experiences that resonate.
It’s great to be able to say that we are changing perceptions, influencing clinical practice and transforming patient lives.
